Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Clin Cancer Res. 2016 Jun 28;22(23):5876–5886. doi: 10.1158/1078-0432.CCR-15-2190

Figure 1. Ganetespib is a potent radiation sensitizer in non-small cell lung cancer cell lines.

Figure 1

Clonogenic survival curves for H460 and A549 (Kras mutant, p53 WT) (A–B), H1650 (Kras WT, p53 mutant) (C) and H1299 (Kras WT and p53 null) (D), cells treated with or without 30 nM ganetespib for 5 hours prior to irradiation followed by an additional 19 hours of post-irradiation incubation in ganetespib containing medium.